Cardiome Oxyprim “Approvable” For Gout, But Product’s Future Now In Doubt
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA requests additional clinical and manufacturing data. Cardiome will “reflect” on FDA’s comments before making a final decision on oxypurinol.